Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Johnson & Johnson buy Maxi_Scalibusa

Johnson & Johnson
Start price
€149.96
28.12.21 / 50%
Target price
-
28.12.22
Performance (%)
10.44%
End price
€165.62
29.12.22
Summary
This prediction ended on 29.12.22 with a price of €165.62. The prediction had a final performance of 10.44%. A total of €4.23 was paid as dividends for this prediction. Maxi_Scalibusa has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y
Johnson & Johnson 2.134% 2.134% -6.813%
iShares Core DAX® 0.000% -2.064% 13.111%
iShares Nasdaq 100 0.626% -2.884% 37.744%
iShares Nikkei 225® 1.568% -5.892% 19.592%
iShares S&P 500 0.334% -2.281% 27.745%

According to Maxi_Scalibusa what are the pros and cons of Johnson & Johnson for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
Cons

Comments by Maxi_Scalibusa for this prediction

In the thread Johnson & Johnson diskutieren

Maxi_Scalibusa hat das Wertpapier Johnson & Johnson in seinem Wikifolio 10 x 10 Trading System gekauft.

Maxi_Scalibusa 
0
Report Share
28.12.21 Buy 10.44%
In the thread Trading Johnson & Johnson
Prediction Buy
Perf. (%) 10.44%
Target price
Change
Ends at 28.12.22

Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten

Maxi_Scalibusa 
0
Report Share
29.12.22

Stopped prediction by Maxi_Scalibusa for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€116.36
17.07.18
€171.83
04.11.21
22.05%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
Maxi_Scalibusa 
15.08.19 50%